Not available
Quote | Avid Bioservices Inc. (NASDAQ:CDMO)
Last: | $7.58 |
---|---|
Change Percent: | 3.55% |
Open: | $7.34 |
Close: | $7.32 |
High: | $7.68 |
Low: | $7.29 |
Volume: | 172,285 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Avid Bioservices Inc. (NASDAQ:CDMO)
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ: CDMO) investors who suffered substantial losses to submit your losses now . Avid Bioservices, Inc. (CDMO) Investigation: Avid Bioservices, Inc. (CDMO) finds itself embro...
2024-04-25 02:44:34 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: A Few Years Away From Large, Relatively Sticky FCF Avid Bioservices Faces Financial Strain Amid Market Challenges (Rating Downgrade) Laughing Water Capital - Avid Bioserv...
Message Board Posts | Avid Bioservices Inc. (NASDAQ:CDMO)
Subject | By | Source | When |
---|---|---|---|
Buy 909K sell 558K | cheynew | investorshub | 06/22/2023 6:02:29 PM |
I guess this works for upcoming options awards. | cheynew | investorshub | 06/22/2023 2:23:05 PM |
Buyvolume 255K sell volume 125K. | cheynew | investorshub | 06/22/2023 2:09:33 PM |
Certainly, the strangest earnings call since Avid has | peregr | investorshub | 06/22/2023 2:01:34 PM |
Flat sales based on what? :: Significant increased | bfiest | investorshub | 06/22/2023 1:48:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ:CDMO) investors who suffered substantial lo...
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ: CDMO) investors who suffered substantial losses to submit your losses now . Avid Bioservices, Inc. (CDMO) Investigation: Avid Bioservices, Inc. (CDMO) finds itself embro...
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 20...